Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1599-1608, April 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okada, K.
Right arrow Articles by Whiteside, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, K.
Right arrow Articles by Whiteside, T. L.

Elimination of Established Liver Metastases by Human Interleukin 2-activated Natural Killer Cells after Locoregional or Systemic Adoptive Transfer1

Kazuhiko Okada, Ulf Nannmark, Nikola L. Vujanovic, Simon Watkins, Per Basse, Ronad B. Herberman and Theresa L. Whiteside2

Departments of Pathology [K. O., N. L. V., P. B., R. B. H., T. L. W.], Medicine [R. B. H.], and Cell Biology and Physiology [S. W.], University of Pittsburgh School of Medicine, and Pittsburgh Cancer Institute [K. O., U. N., N. L. V., S. W., P. B., R. B. H., T. L. W.], Pittsburgh, Pennsylvania 15213, and Department of Anatomy and Cell Biology, University of Goteborg, Goteborg, Sweden [U. N.]

An in vivo model of liver metastasis induced by human gastric carcinoma was established in nude mice and used for locoregional or systemic immunotherapy with a subset of human A-natural killer (NK) cells defined previously. A single intrasplenic (i.s.) delivery of A-NK cells (1 x 107) and interleukin 2 (IL-2; 60,000 international units, twice a day for 5 days, i.p.) to animals with 3-day established liver metastases, but not IL-2 alone, resulted in rapid (within 24 h) elimination of the majority of metastases and significantly improved survival. A single i.s. or i.v. transfer of these effector cells and IL-2 significantly prolonged survival of the mice with 3-day established metastases (P < 0.03 and P < 0.02, respectively) compared with untreated mice. Using 51Cr-labeled A-NK cells, it was determined that, at best, 75% of 1 x 107 cells delivered i.s., and up to 50% of those delivered i.v. were found in the liver 30 min-4 h later. Using image analysis with Di-O dye-labeled A-NK cells, 60–100% of A-NK cells delivered i.s. or i.v. were detected in the liver 24 h later. By light microscopy, 3-day liver metastases were mostly intravascular, but some had already begun to spread into liver tissue. When rhodamine- or Di-O dye-labeled A-NK cells were injected i.s. or i.v. to study their distribution in the liver, they were detectable by confocal fluorescence microscopy in tumor-free tissue and in association with tumor cells 12–24 h after transfer. No evidence for selective localization of A-NK cells to liver metastases was obtained; many A-NK cells were randomly distributed in tissue and not associated with visible metastases. However, confocal fluorescence and electron microscopy showed some A-NK cells to be in cell-to-cell contact with tumor cells, both in the blood vessels and liver tissue. These results indicate that a majority of human A-NK cells transferred i.s. or i.v. to mice with liver metastases have the capacity to migrate to the liver and to enter liver tissue and tumor metastases in vivo. The presence of these effector cells even in a modest number in the liver leads to elimination of most, but not all, metastases and to significantly prolonged survival of animals treated with A-NK cells and IL-2.

1 This work was supported in part by American Cancer Society Grants IM-696 (T. L. W.) and IM-713 (N. L. V.), NIH Grant RO1-CA63513 (T. L. W.), Danish Cancer Society Grant 90-086 (P. B.), Swedish Cancer Society Grant 1000 (U. N.), and the Pathology, Education, and Research Foundation (Pittsburgh, PA).

2 To whom requests for reprints should be addressed, at Pittsburgh Cancer Institute. W1041 Biomedical Science Tower, 211 Lothrop Street, Pittsburgh, PA 15213. Phone: (412) 624-0096; Fax: (412) 624-0264.

Received 8/31/95. Accepted 2/ 1/96.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. A. Maghazachi
G protein-coupled receptors in natural killer cells
J. Leukoc. Biol., July 1, 2003; 74(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Inngjerdingen, B. Damaj, and A. A. Maghazachi
Expression and regulation of chemokine receptors in human natural killer cells
Blood, January 15, 2001; 97(2): 367 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kjaergaard and S. Shu
Tumor Infiltration by Adoptively Transferred T Cells Is Independent of Immunologic Specificity but Requires Down-Regulation of L-Selectin Expression
J. Immunol., July 15, 1999; 163(2): 751 - 759.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Yao, C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato
Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Blood, March 1, 1999; 93(5): 1612 - 1621.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nagashima, R. Mailliard, Y. Kashii, T. E. Reichert, R. B. Herberman, P. Robbins, and T. L. Whiteside
Stable Transduction of the Interleukin-2 Gene Into Human Natural Killer Cell Lines and Their Phenotypic and Functional Characterization In Vitro and In Vivo
Blood, May 15, 1998; 91(10): 3850 - 3861.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.